🔗 Permalink

Assignee profile:

Cartesian Therapeutics, Inc.

City:

Gaithersburg, Maryland

Country:

United States

Published Applications:

Last publication date:

2025-06-05

Patent Grants:

Last grant date:

2025-01-14

Top Inventors for applications by Cartesian Therapeutics, Inc.

These are the the leading inventors for applications assigned to Cartesian Therapeutics, Inc.:

Murat V. Kalayoglu 6 Silver Spring, MD United States
C. Andrew Stewart 6 Frederick, MD United States
Metin Kurtoglu 6 Bethesda, MD United States
Yi Zhang 5 Gaithersburg, MD United States

Lloyd Johnston 4 Belmont, MA United States
Michael S. Singer 4 Chestnut Hill, MA United States
Takashi Kei Kishimoto 3 Lexington, MA United States
Earl Sands 2 Alpharetta, GA United States

Werner Cautreels 2 Boston, MA United States
Roberto A. Maldonado 1 Berkeley, CA United States
Conlin O'Neil 1 Andover, MA United States
Yi Zhang 1 Potomac, MD United States

Murat Kalayoglu 1 Silver Spring, MD United States
David H. Altreuter 1 Wayland, MA United States
Minhtran Ngo Casi 1 Gaithersburg, MD United States
Shaji Daniel 1 Germantown, MD United States

Sjaji Daniel 1 Germantown, MD United States
Aaron P. Griset 1 Somerville, MA United States

Recent patent applications by Cartesian Therapeutics, Inc.

Cartesian Therapeutics, Inc. based in Gaithersburg, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-06-05

US20250177360A1

Human necessities

METHODS RELATED TO ADMINISTERING IMMUNOSUPPRESSANTS AND THERAPEUTIC MACROMOLECULES AT A REDUCED PHARMACODYNAMICALLY EFFECTIVE DOSE

#2 | 2025-05-15

US20250152561A1

Human necessities

METHODS AND COMPOSITIONS RELATED TO SYNTHETIC NANOCARRIERS WITH RAPAMYCIN IN A STABLE, SUPER-SATURATED STATE

#3 | 2025-04-03

US20250108094A1

Human necessities

METHODS AND COMPOSITIONS RELATED TO COMBINED TREATMENT WITH ANTI-INFLAMMATORIES AND SYNTHETIC NANOCARRIERS COMPRISING AN IMMUNOSUPPRESSANT

#4 | 2025-03-20

US20250090451A1

Human necessities

FORMULATIONS AND DOSES OF PEGYLATED URICASE

#5 | 2025-02-20

US20250057756A1

Human necessities

FORMULATIONS AND DOSES OF PEGYLATED URICASE

#6 | 2024-10-17

US20240344030A1

Chemistry; metallurgy

MULTIPROTEIN-ENGINEERED CELLS SECRETING A MULTISPECIFIC ANTIBODY

#7 | 2024-09-05

US20240294600A1

Chemistry; metallurgy

ANTI-BCMA CHIMERIC ANTIGEN RECEPTORS

#8 | 2023-06-08

US20230174944A1

Chemistry; metallurgy

ENGINEERED CELLS SECRETING THERAPEUTIC ENZYMES

#9 | 2023-04-20 ✅ Patent 12,194,078 granted on 2025-01-14

US20230119226A1

Human necessities

Methods and compositions related to combined treatment with anti-inflammatories and synthetic nanocarriers comprising an immunosuppressant

#10 | 2022-03-24 ✅ Patent 11,999,773 granted on 2024-06-04

US20220089678A1

Chemistry; metallurgy

Anti-BCMA chimeric antigen receptors

#11 | 2021-07-22 ✅ Patent 11,220,535 granted on 2022-01-11

US20210221868A1

Chemistry; metallurgy

Anti-BCMA chimeric antigen receptors

#12 | 2020-09-17 ✅ Patent 10,934,337 granted on 2021-03-02

US20200291087A1

Chemistry; metallurgy

Anti-BCMA chimeric antigen receptors

Also check out Cartesian Therapeutics, Inc.'s (Gaithersburg, United States) applicant profile with 11 patent applications submitted.

AssigneeID:

312995 ⎘